{
  "docId": "019de074-05b7-71fd-bc3c-27f1b7be8924",
  "docSlug": "c3cb552ef3a6b077a714c97117e1fe86",
  "documentTitle": "Mink Therapeutics | Investor Day Presentation Deck | 92 slides",
  "authorId": "mink-therapeutics",
  "authorName": "MiNK Therapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 53,
  "pageCount": 92,
  "prevPage": 52,
  "nextPage": 54,
  "slideType": "propose_solution",
  "function": "propose_solution",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a circular flow diagram to suggest a cycle of improvement or replacement of existing therapies.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-05b7-71fd-bc3c-27f1b7be8924/53",
  "deckHref": "/decks/019de074-05b7-71fd-bc3c-27f1b7be8924",
  "deckJsonHref": "/decks/019de074-05b7-71fd-bc3c-27f1b7be8924.json",
  "deckAnchorHref": "/decks/019de074-05b7-71fd-bc3c-27f1b7be8924#slide-53",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.58,
        "x": 0.21,
        "y": 0.22
      },
      "kind": "diagram",
      "text": "Circular process flow connecting MiNK-413, Why are we better?, and Limitations of BCMA CAR-T cell therapy",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f6f75b05-5b73-440f-abf8-5d65f243bc9d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.16,
        "w": 0.26,
        "x": 0.5,
        "y": 0.575
      },
      "kind": "list",
      "text": "Limitations of BCMA CAR-T cell therapy: 1. Sub-optimal CARs 2. Clinical challenges 3. Logistical challenges",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c3df97b8-1a6c-4938-baf0-a9e65c4e3988",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.16,
        "w": 0.28,
        "x": 0.209,
        "y": 0.575
      },
      "kind": "list",
      "text": "Why are we better? 1. CARDIS – functional selection 2. iNKT cells - more than just kill tumor cells 3. Manufacturing process - >5000 doses from a single healthy donor",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dcf327ca-6393-494d-a9bd-64cea2294b00",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.294,
        "x": 0.353,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "MiNK-413 for Multiple Myeloma: allogenic BCMA-CAR iNKT cell therapy - opportunity for partnership",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "91724803-08e7-4012-9426-d9022b78e779",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.65,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "MiNK-413: Not another BCMA CAR T-Cell Therapy",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cefaa5a9-2862-48a7-9af8-ea916166f370",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem-Agitate-Solve (PAS)",
      "slug": "problem-agitate-solve-pas",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "2154268b-1f1f-4c7d-8944-d8bea8ee21f7",
      "evidence": "The slide discusses limitations of BCMA CAR-T cell therapy and presents MiNK-413 as a solution, following the PAS framework.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "3148a20d-615a-4665-8209-936f24d2286a",
      "evidence": "Contrasts current limitations with proposed solution advantages",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}